Identification of choriocarcinoma by the hCGβ-to-hCG proportion in patients with delayed diagnosis caused by contraceptive use

Contraception

Volumn 57, Issue 4, 1998, Pages 257-260

  Vartiainen, Juhani ^a   Alfthan, Henrik ^a   Lehtovirta, Pentti ^a   Stenman, Ulf Håkan ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Choriocarcinoma; Contraceptives; Human chorionic gonadotropin; Human chorionic gonadotropin

Indexed keywords

CARBOPLATIN; CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; CISPLATIN; CONTRACEPTIVE AGENT; COPPER INTRAUTERINE DEVICE; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; LEVONORGESTREL; METHOTREXATE; VINCRISTINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CASE REPORT; CHORIOCARCINOMA; CONTRACEPTION; DRUG IMPLANT; FEMALE; HORMONE BLOOD LEVEL; HUMAN; IMMUNOASSAY; SUBCUTANEOUS DRUG ADMINISTRATION;

BIOLOGY; CANCER--ETIOLOGY; CASE STUDIES; CONTRACEPTION; DEVELOPED COUNTRIES; DISEASES; ENDOCRINE SYSTEM; EUROPE; FAMILY PLANNING; FINLAND; GONADOTROPINS; GONADOTROPINS, CHORIONIC; HORMONES; HYDATIDIFORM MOLE; NEOPLASMS; NORTHERN EUROPE; PHYSIOLOGY; PREGNANCY COMPLICATIONS; RESEARCH METHODOLOGY; RESEARCH REPORT; SCANDINAVIA; SIGNS AND SYMPTOMS; STUDIES;

ADULT; CHORIOCARCINOMA; CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CONTRACEPTIVE AGENTS, FEMALE; DRUG IMPLANTS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INTRAUTERINE DEVICES; LEVONORGESTREL; PREGNANCY; TIME FACTORS; TREATMENT OUTCOME; UTERINE HEMORRHAGE; UTERINE NEOPLASMS;

EID: 0031868047     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(98)00028-6     Document Type: Article

References (19)

1. Lurain J.R., Brewer J.I., Mazur M.T., Torok E.E. Fatal gestational trophoblastic disease an analysis of treatment failures . Am J Obstet Gynecol. 144:1982;391-395.
2. Lurain J.R., Brewer J.I., Torok E.E., Halpern B. Gestational trophoblastic disease treatment results at the Brewer Trophoblastic Disease Center . Obstet Gynecol. 60:1982;354-360.
3. Tidy J.A., Rustin G.J., Newlands E.S., et al. Presentation and management of choriocarcinoma after nonmolar pregnancy. Br J Obstet Gynecol. 102:1995;715-719.
4. Stenman U.-H., Alfthan H., Halila H. Determination of chorionic gonadotropin in serum of nonpregnant subjects and patients with trophoblastic cancer by time-resolved immunofluorometric assay. Tumor Biol. 5:1985;97.
5. Khazaeli M.B., Buchina E.S., Pattillo R.A., Soong S.-J., Hatch K.D. Radioimmunoassay of the free β-subunit of human chorionic gonadotropin in diagnosis of high-risk and low-risk gestational trophoblastic disease. Am J Obstet Gynecol. 160:1989;444-449.
6. Bagshawe K.D. From methotrexate to EMA/CO. Szulman A.E., Buchsbaum H.J. Gestational Trophoblastic Disease. 1987;127-134 Springer-Verlag, New York.
7. Lurain J.R. Natural history. Szulman A.E., Buchsbaum H.J. Gestational Trophoblastic Disease. 1987;62-74 Springer-Verlag, New York.
8. Alfthan H., Schröder J., Fraser R., et al. Choriogonadotropin and its β-subunit separated by hydrophobic-interaction chromatography and quantified in serum during pregnancy by time-resolved immunofluorometric assays. Clin Chem. 34:1988;1758-1762.
9. Stenman U.-H., Alfthan H., Ranta T., et al. Serum levels of human chorionic gonadotropin in nonpregnant women and men are modulated by gonadotropin-releasing hormone and sex steroids. J Clin Endocrinol Metab. 64:1987;730-736.
10. Alfthan H., Haglund C., Dabek J., Stenman U.-H. Concentrations of hCG, βhCG and cβhCG in serum and urine of nonpregnant women and men. Clin Chem. 38:1992;1981-1987.
11. Bagshawe K.D. Choriocarcinoma. A model for tumor markers. Acta Oncol. 31:1992;99-106.
12. Hertig AT, Mansell H. Atlas of Tumor Pathology. Tumor of the Female Sex Organs. Part 1. Hydatiform Mole and Choriocarcinoma. Washington, DC: Armed Forces Institute of Pathology, 1956: Sect. 9, Fascile 33.
13. Bagshawe K.D., Dent J., Webb J. Hydatiform mole in England and Wales 1972-1983. Lancet. 2:1986;673-677.
14. Rice L.W., Lage J.M., Berkowitz R.S., Goldstein D.P., Bernstein M.R. Repetitive complete and partial hydatiform mole. Obstet Gynecol. 74:1989;217-219.
15. Shoupe D., Mishell D.R. Jr, Bopp B.L., Felding M. The significance of bleeding patterns in Norplant implant users. Obstet Gynecol. 77:1991;256-260.
16. Anderson O., Odlind V., Rybo G. Levonorgestrel-releasing and copper-releasing (Nova-T) IUD during five years of use a randomised comparative trial . Contraception. 49:1994;56-72.
17. Marcillac I., Troalen F., Bidart J.-M., et al. Free human chorionic gonadotropin β-subunit in gonadal and nongonadal neoplasms. Cancer Res. 52:1992;3901-3907.
18. Carter P.G., Iles R.K., Neven P., et al. The prognostic significance of urinary β-core fragment in premenopausal women with carcinoma of the cervix. Gynecol Oncol. 55:1994;271-276.
19. Bagshawe K. Risk and prognostic factors in trophoblastic neoplasia. Cancer. 38:1976;1373-1385.